Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,441
Closed -$840K 732
2025
Q4
$840K Buy
7,441
+427
+6% +$40.8K 0.02% 300
2025
Q3
$572K Sell
7,014
-81
-1% -$7.44K 0.01% 327
2025
Q2
$733K Sell
7,095
-290
-4% -$27.2K 0.02% 272
2025
Q1
$727K Sell
7,385
-3,167
-30% -$422K 0.02% 227
2024
Q4
$1.58M Buy
10,552
+2
+0% +$276 0.04% 150
2024
Q3
$1.37M Buy
+10,550
New +$1.31M 0.04% 159
2023
Q1
Sell
-23,337
Closed -$1.02M 364
2022
Q4
$1.02M Hold
23,337
0.04% 161
2022
Q3
$1.24M Buy
23,337
+19,045
+444% +$983K 0.05% 135
2022
Q2
$195K Hold
4,292
0.01% 316
2022
Q1
$248K Hold
4,292
0.01% 312
2021
Q4
$191K Hold
4,292
0.01% 372
2021
Q3
$206K Hold
4,292
0.01% 336
2021
Q2
$364K Hold
4,292
0.01% 275
2021
Q1
$360K Buy
4,292
+1,514
+54% +$133K 0.02% 244
2020
Q4
$209K Hold
2,778
0.01% 227
2020
Q3
$138K Hold
2,778
0.01% 244
2020
Q2
$107K Hold
2,778
0.01% 262
2020
Q1
$85.7K Hold
2,778
0.01% 279
2019
Q4
$151K Hold
2,778
0.02% 263
2019
Q3
$174K Buy
+2,778
New +$196K 0.02% 278

Other funds holding GKOS

Evoke Wealth's GKOS Position: Q1 2026 in Review

Evoke Wealth sold out of Glaukos (GKOS) in Q1 2026, closing a stake of 7,441 shares — an estimated $840K sold.

Evoke Wealth first reported a position in GKOS in Q3 2019 and held it in 20 quarters. The position peaked at $1.58M in Q4 2024. 336 funds tracked by Wall St. Rank hold GKOS as of Q1 2026.

  • Evoke Wealth reported no remaining Glaukos position as of Q1 2026 after selling out during the quarter.
  • Evoke Wealth sold 7,441 Glaukos shares in Q1 2026, an estimated $840K.
  • Evoke Wealth first reported a position in Glaukos in Q3 2019 and held it in 20 quarters.
  • Evoke Wealth's Glaukos position peaked at $1.58M in Q4 2024.
  • 336 funds tracked by Wall St. Rank held Glaukos as of Q1 2026.

Based on Evoke Wealth's 13F filing for Q1 2026, filed 15 May 2026.